PL3829553T3 - Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego - Google Patents

Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego

Info

Publication number
PL3829553T3
PL3829553T3 PL19746480.3T PL19746480T PL3829553T3 PL 3829553 T3 PL3829553 T3 PL 3829553T3 PL 19746480 T PL19746480 T PL 19746480T PL 3829553 T3 PL3829553 T3 PL 3829553T3
Authority
PL
Poland
Prior art keywords
prevention
treatment
composition
genitourinary mucosa
genitourinary
Prior art date
Application number
PL19746480.3T
Other languages
English (en)
Inventor
Deborah RODRIGUEZ VILABOA
Original Assignee
Mucosa Innovations, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucosa Innovations, S.L. filed Critical Mucosa Innovations, S.L.
Publication of PL3829553T3 publication Critical patent/PL3829553T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL19746480.3T 2018-07-31 2019-07-31 Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego PL3829553T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382576.9A EP3603626A1 (en) 2018-07-31 2018-07-31 Composition for use in the prevention and/or treatment of the genitourinary mucosa
PCT/EP2019/070588 WO2020025657A1 (en) 2018-07-31 2019-07-31 Composition for use in the prevention and/or treatment of the genitourinary mucosa

Publications (1)

Publication Number Publication Date
PL3829553T3 true PL3829553T3 (pl) 2025-04-07

Family

ID=63244524

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19746480.3T PL3829553T3 (pl) 2018-07-31 2019-07-31 Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego

Country Status (10)

Country Link
US (1) US12016894B2 (pl)
EP (2) EP3603626A1 (pl)
JP (1) JP7252317B2 (pl)
CN (1) CN112770765B (pl)
AU (1) AU2019313547B2 (pl)
BR (1) BR112021001873A2 (pl)
ES (1) ES3003989T3 (pl)
MX (1) MX2021001228A (pl)
PL (1) PL3829553T3 (pl)
WO (1) WO2020025657A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL295912A (en) * 2020-02-28 2022-10-01 Mucosa Innovations S L Preparations for the treatment of dysbiosis
WO2024079251A1 (en) * 2022-10-12 2024-04-18 Bioactor Bv Non-therapeutic use of a composition comprising oleuropein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI106923B (fi) * 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AU2002221567A1 (en) 2000-12-15 2002-06-24 Novo-Nordisk A/S Use of an oestrogen in the manufacture of a composition containing oestrogen forthe treatment of atrophic vaginitis
ITMI20030195A1 (it) * 2003-02-06 2004-08-07 Bsd Bioscience Dev Snc Di O Mini C E Zucc Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
CA2637608A1 (en) 2006-01-20 2007-07-26 Pear Tree Pharmaceuticals, Inc. Method of treating atrophic vaginitis
US20080193489A1 (en) * 2007-02-13 2008-08-14 Robert De Armond Personal Lubricant Compositions That Are Free Of Glycerin and Parabens
ES2304103B1 (es) * 2007-02-22 2009-08-07 Biocosmetics S.L. Composicion para tratamiento de la xerostomia o boca seca.
JP5930713B2 (ja) * 2009-03-30 2016-06-08 ライオン株式会社 口腔用組成物
IT1405998B1 (it) * 2010-12-09 2014-02-06 Bionest Ltd Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato
CN102526095A (zh) * 2012-02-14 2012-07-04 济南康众医药科技开发有限公司 一种治疗卡他症的药物组合物

Also Published As

Publication number Publication date
US12016894B2 (en) 2024-06-25
ES3003989T3 (en) 2025-03-11
JP7252317B2 (ja) 2023-04-04
US20210322505A1 (en) 2021-10-21
BR112021001873A2 (pt) 2021-05-11
CN112770765A (zh) 2021-05-07
CN112770765B (zh) 2022-12-02
MX2021001228A (es) 2021-05-12
EP3829553C0 (en) 2024-12-11
WO2020025657A9 (en) 2020-05-22
EP3829553B1 (en) 2024-12-11
EP3603626A1 (en) 2020-02-05
EP3829553A1 (en) 2021-06-09
JP2021533123A (ja) 2021-12-02
AU2019313547B2 (en) 2024-08-29
WO2020025657A1 (en) 2020-02-06
AU2019313547A1 (en) 2021-02-25

Similar Documents

Publication Publication Date Title
IL268327A (en) A pharmaceutical preparation for use in the treatment and prevention of c5-related diseases and methods for the treatment and prevention of c5-related diseases
PL3593817T3 (pl) Kompozycja do zastosowania w zapobieganiu lub hamowaniu krótkowzroczności
IL275626A (en) Preparations and methods for surface treatment
IL261932A (en) Use of probiotics in the treatment and/or prevention of eczema
SG11202100675YA (en) Surface treatment compositions and methods
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
IL290348B1 (en) Compositions and methods for surface treatment
IL282904A (en) Therapeutic microbiota for the treatment and/or prevention of dysbiosis
IL289758B2 (en) Proportin inhibitors for use in the prevention and treatment of kidney injury
ZA202307970B (en) Compounds for use in the treatment and prevention of covid- 19
HUE073261T2 (hu) Készítmények fehérje-aggregációs betegségek kezelésére és/vagy megelõzésére
IL273297A (en) Gluconic acid derivatives for use in the treatment and/or prevention of bacterial infections
PT3661490T (pt) Composição para utilização na prevenção e/ou tratamento de mucositite oral gastrointestinal induzida por tratamento oncológico
PL3541185T3 (pl) Zastosowanie 2-hydroksybenzyloaminy w leczeniu i zapobieganiu nadciśnieniu płucnemu
PL3829553T3 (pl) Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego
IL261834A (en) Cd31shed agonists for use in the prevention and/or treatment of reperfusion injury
PL3937949T3 (pl) Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu upośledzenia funkcji oddechowych
IL268860A (en) Granzyme B inhibitor preparations and methods for preventing and/or treating blistered and/or peeling skin
GB2610895B (en) Composition for use in the treatment and/or prevention of mycotoxic disease
PL3813843T3 (pl) Kompozycja do stosowania w zapobieganiu i/lub leczeniu chorób układu kostno-stawowego
HK40020769A (en) Composition for use in the prevention and in the treatment of iron deficiency
IL261240B (en) Preparations useful in the prevention and/or treatment of inflammation and pain
HUE052035T2 (hu) Legalább egy proteáz ihibitor és dexpantenol kombinációja bõrsérülések megelõzésében és/vagy kezelésében történõ alkalmazásra
GB202107297D0 (en) Composition for use in the treatment and/or prevention of mycotoxic disease
HK40073865A (en) Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof